(Q42627416)

4 November 2017

title

Leflunomide in the treatment of psoriasis: results of a phase II open trial (English)

1 reference

4 November 2017

main subject

phase II clinical trial

0 references

author name string

Tlacuilo-Parra JA

1

1 reference

4 November 2017

Guevara-Gutiérrez E

2

1 reference

4 November 2017

Rodríguez-Castellanos MA

3

1 reference

4 November 2017

Ornelas-Aguirre JM

4

1 reference

4 November 2017

Barba-Gómez JF

5

1 reference

4 November 2017

Salazar-Páramo M

6

1 reference

4 November 2017

language of work or name

English

0 references

publication date

1 May 2004

1 reference

British Journal of Dermatology

4 November 2017

published in

1 reference

4 November 2017

volume

150

1 reference

4 November 2017

issue

5

1 reference

4 November 2017

page(s)

970-976

1 reference

Interleukin 10 treatment of psoriasis: clinical results of a phase 2 trial

4 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.05836.X

The immunologic basis for the treatment of psoriasis with new biologic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.05836.X

Psoriasis: current perspectives with an emphasis on treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.05836.X

Importance of ribonucleotide availability to proliferating T-lymphocytes from healthy humans. Disproportionate expansion of pyrimidine pools and contrasting effects of de novo synthesis inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.05836.X

Leflunomide: mode of action in the treatment of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.05836.X

Treatment of severe psoriasis and psoriatic arthritis with leflunomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.05836.X

Leflunomide decreases joint erosions and induces reparative changes in a patient with psoriatic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.05836.X

The efficacy and safety of leflunomide in patients with active rheumatoid arthritis: a five-year followup study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.05836.X

Treatment of active rheumatoid arthritis with leflunomide: two year follow up of a double blind, placebo controlled trial versus sulfasalazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.05836.X

Teratogen update: reproductive risks of leflunomide (Arava); a pyrimidine synthesis inhibitor: counseling women taking leflunomide before or during pregnancy and men taking leflunomide who are contemplating fathering a child

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.05836.X

CD69, HLA-DR and the IL-2R identify persistently activated T cells in psoriasis vulgaris lesional skin: blood and skin comparisons by flow cytometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.05836.X

The majority of epidermal T cells in Psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.05836.X

Restriction of de novo pyrimidine biosynthesis inhibits Th1 cell activation and promotes Th2 cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.05836.X

10.1111/J.1365-2133.2004.05836.X

21 January 2018

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nyecydv5kvgynfo6gevjpuzuai

mapped directly with Wikidata item

30 July 2022

based on heuristic

Fatcat ID

release_nyecydv5kvgynfo6gevjpuzuai

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nyecydv5kvgynfo6gevjpuzuai

mapped directly with Wikidata item

30 July 2022

based on heuristic

https://api.fatcat.wiki/v0/release/nyecydv5kvgynfo6gevjpuzuai

1 reference